| [1] |
杜建, 李爱花, 唐小利, 等. 我国医药卫生人才培养战略研究[J]. 中国工程科学, 2019,21(2):63-68.
|
| [2] |
National Institute of Science and Technology Policy (NISTEP). Japanese science and technology indicators 2016[M]. Tokyo: National Institute of Science and Technology Policy, 2016: 112-113.
|
| [3] |
DeSalvo KB, O’Carroll PW, Koo D, et al. Public health 3.0: time for an upgrade[J]. Am J Public Health, 2016,106(4):621-622.
doi: 10.2105/AJPH.2016.303063
pmid: 26959263
|
| [4] |
Godlee F, Waters A. Healthy people, healthy animals, and a healthy environment: one health[J]. BMJ, 2018,362:k3020.
doi: 10.1136/bmj.k3020
pmid: 30002016
|
| [5] |
National Institute of Science and Technology Policy (NISTEP). Japanese Science and Technology Indicators 2019[M]. Tokyo: National Institute of Science and Technology Policy, 2019: 145-146.
|
| [6] |
Tollefson J. China declared world’s largest producer of scientific articles[J]. Nature, 2018,553(7689):390.
pmid: 32094808
|
| [7] |
Branswell H, Thielking M. Fluctuating funding and flagging interest hurt coronavirus research, leaving crucial knowledge gaps[EB/OL]. ( 2020-02-10) [2020-04-30]. https://www.statnews.com/2020/02/10/fluctuating-funding-and-flagging-interest-hurt-coronavirus-research/.
|
| [8] |
Thanh Le T, Andreadakis Z, Kumar A, et al. The COVID-19 vaccine development landscape[J/OL]. Nat Rev Drug Discov ( 2020- 04- 09) [2020-04-30]. doi: 10.1038/d41573-020-00073-5. http://www.nature.com/articles/d41573-020-00073-5.
|
| [9] |
国家卫生健康委员会. 2019中国卫生健康统计年鉴[M]. 北京: 中国协和医科大学出版社, 2019: 40-66.
|
| [10] |
郭锋, 张毓辉, 万泉, 等. 2017年中国卫生总费用核算结果与分析[J]. 中国卫生经济, 2019,38(4):5-8.
|
| [11] |
张毓辉, 万泉, 翟铁民, 等. 2012年中国卫生总费用核算结果与分析[J]. 中国卫生经济, 2014,33(2):5-9.
|
| [12] |
罗力, 王颖, 张天天. 新时代疾病预防控制体系建设的思考[J]. 中国卫生资源, 2020,23(1):7-13.
|
